Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
769.60
652.89
601.45
555.51
600.18
548.12
341.46
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
769.60
652.89
601.45
555.51
600.18
548.12
341.46
Raw Material Cost
387.98
348.77
344.28
317.79
379.07
347.94
168.47
Purchase of Finished goods
10.76
25.04
13.07
5.16
4.43
0.00
0.00
(Increase) / Decrease In Stocks
-11.47
4.81
-2.66
8.04
3.48
-7.15
5.86
Employee Cost
88.68
80.49
71.50
61.33
56.18
46.02
46.02
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
-0.01
Selling and Distribution Expenses
146.37
125.24
115.66
103.17
94.91
107.54
80.33
Other Expenses
0.00
0.00
0.00
0.00
-0.00
-0.01
0.01
Total Expenditure (Excl Depreciation)
622.32
584.35
541.85
495.49
538.07
494.34
300.68
Operating Profit (PBDIT) excl Other Income
147.28
68.54
59.60
60.02
62.11
53.78
40.78
Other Income
12.58
15.95
11.58
10.32
8.31
19.63
5.31
Operating Profit (PBDIT)
159.86
84.49
71.18
70.34
70.42
73.41
46.09
Interest
0.04
0.07
0.09
0.12
0.48
13.02
13.31
Exceptional Items
0.00
9.91
0.00
0.00
0.00
23.44
-8.81
Gross Profit (PBDT)
159.82
94.33
71.09
70.22
69.94
83.83
23.97
Depreciation
25.66
22.51
26.45
32.30
33.53
35.28
32.01
Profit Before Tax
134.16
71.82
44.64
37.92
36.41
48.55
-8.03
Tax
31.37
26.50
16.16
11.36
-4.32
-13.21
1.96
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
102.79
45.32
28.48
26.56
40.73
61.77
-10.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
102.79
45.32
28.48
26.56
40.73
61.77
-10.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
102.79
45.32
28.48
26.56
40.73
61.77
-10.00
Equity Capital
13.37
13.37
13.37
13.37
13.37
12.34
12.34
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
650.38
547.58
474.18
446.97
427.08
387.94
311.03
Earnings per share (EPS)
76.88
33.9
21.3
19.87
30.46
50.06
-8.1
Diluted Earnings per share
76.89
33.9
21.31
19.88
30.86
50.04
-8.1
Operating Profit Margin (Excl OI)
19.14%
10.5%
9.91%
10.8%
10.35%
9.81%
11.94%
Gross Profit Margin
20.77%
14.45%
11.82%
12.64%
11.65%
15.29%
7.02%
PAT Margin
13.36%
6.94%
4.74%
4.78%
6.79%
11.27%
-2.93%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 17.88% vs 8.55% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 126.81% vs 59.13% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 114.88% vs 15.00% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -42.86% vs -22.22% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Venus Remedies With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
769.60
503.08
266.52
52.98%
Other Operating Income
0.00
0.00
0.00
Total Operating income
769.60
503.08
266.52
52.98%
Raw Material Cost
387.98
240.81
147.17
61.11%
Purchase of Finished goods
10.76
17.35
-6.59
-37.98%
(Increase) / Decrease In Stocks
-11.47
0.28
-11.75
-4,196.43%
Employee Cost
88.68
54.04
34.64
64.10%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
146.37
0.00
146.37
Other Expenses
0.00
72.37
-72.37
-100.00%
Total Expenditure (Excl Depreciation)
622.32
384.84
237.48
61.71%
Operating Profit (PBDIT) excl Other Income
147.28
118.24
29.04
24.56%
Other Income
12.58
2.86
9.72
339.86%
Operating Profit (PBDIT)
159.86
121.10
38.76
32.01%
Interest
0.04
10.97
-10.93
-99.64%
Exceptional Items
0.00
-0.83
0.83
100.00%
Gross Profit (PBDT)
159.82
109.30
50.52
46.22%
Depreciation
25.66
19.81
5.85
29.53%
Profit Before Tax
134.16
89.49
44.67
49.92%
Tax
31.37
22.15
9.22
41.63%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
102.79
67.35
35.44
52.62%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
102.79
67.35
35.44
52.62%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
102.79
67.35
35.44
52.62%
Equity Capital
13.37
10.38
2.99
28.81%
Face Value
10.00
10.00
0.00
Reserves
650.38
320.42
329.96
102.98%
Earnings per share (EPS)
76.88
64.88
12.00
18.50%
Diluted Earnings per share
76.89
64.90
11.99
18.47%
Operating Profit Margin (Excl OI)
19.14%
23.50%
0.00
-4.36%
Gross Profit Margin
20.77%
21.73%
0.00
-0.96%
PAT Margin
13.36%
13.39%
0.00
-0.03%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 769.60 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 17.88% vs 8.55% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 102.79 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 126.81% vs 59.13% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 147.28 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 114.88% vs 15.00% in Mar 2025
Annual - Interest
Interest 0.04 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -42.86% vs -22.22% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.14%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025
